SwePub
Sök i LIBRIS databas

  Extended search

onr:"19977702"
 

Search: onr:"19977702" > Statistical power c...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Statistical power considerations in genotype-based recall randomized controlled trials

Atabaki-Pasdar, Naeimeh (author)
Ohlsson, Mattias (author)
Shungin, Dmitry (author)
show more...
Kurbasic, Azra (author)
Ingelsson, Erik (author)
Pearson, Ewan R. (author)
Ali, Ashfaq (author)
Franks, Paul W. (author)
show less...
 (publisher)
2016
2016
English.
In: Scientific Reports. - 2045-2322. ; 6
  • swepub:Mat__t
Abstract Subject headings
Close  
  • Randomized controlled trials (RCT) are often underpowered for validating gene-treatment interactions. Using published data from the Diabetes Prevention Program (DPP), we examined power in conventional and genotype-based recall (GBR) trials. We calculated sample size and statistical power for genemetformin interactions (vs. placebo) using incidence rates, gene-drug interaction effect estimates and allele frequencies reported in the DPP for the rs8065082 SLC47A1 variant, a metformin transported encoding locus. We then calculated statistical power for interactions between genetic risk scores (GRS), metformin treatment and intensive lifestyle intervention (ILI) given a range of sampling frames, clinical trial sample sizes, interaction effect estimates, and allele frequencies; outcomes were type 2 diabetes incidence (time-to-event) and change in small LDL particles (continuous outcome). Thereafter, we compared two recruitment frameworks: GBR (participants recruited from the extremes of a GRS distribution) and conventional sampling (participants recruited without explicit emphasis on genetic characteristics). We further examined the influence of outcome measurement error on statistical power. Under most simulated scenarios, GBR trials have substantially higher power to observe gene-drug and gene-lifestyle interactions than same-sized conventional RCTs. GBR trials are becoming popular for validation of gene-treatment interactions; our analyses illustrate the strengths and weaknesses of this design.

Subject headings

Medical and Health Sciences  (hsv)
Clinical Medicine  (hsv)
Endocrinology and Diabetes  (hsv)
Medicin och hälsovetenskap  (hsv)
Klinisk medicin  (hsv)
Endokrinologi och diabetes  (hsv)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view